AI's Transformative Role in Drug Design and Development

After pioneering reinforcement learning breakthroughs at DeepMind with Capture the Flag and AlphaStar, Max Jaderberg aims to revolutionize drug discovery with AI as Chief AI Officer of Isomorphic Labs, which was spun out of DeepMind. He discusses how AlphaFold 3's diffusion-based architecture enables unprecedented understanding of molecular interactions, and why we're approaching a "Move 37 moment" in AI-powered drug design where models will surpass human intuition. Max shares his vision for general AI models that can solve all diseases, and the importance of developing agents that can learn to search through the whole potential design space.

Hosted by Stephanie Zhan, Sequoia capital

Mentioned in this episode: 

• Playing Atari with Deep Reinforcement Learning: Seminal 2013 paper on Reinforcement Learning 

• Capture the Flag: 2019 DeepMind paper on the emergence of cooperative agents

• AlphaStar: 2019 DeepMind paper on attaining grandmaster level in StarCraft II using multi-agent RL

  AlphaFold Server: Web interface for AlphaFold 3 model for non-commercial academic use